Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation.
作者信息
Drew Barbara J, Ackerman Michael J, Funk Marjorie, Gibler W Brian, Kligfield Paul, Menon Venu, Philippides George J, Roden Dan M, Zareba Wojciech
出版信息
Circulation. 2010 Mar 2;121(8):1047-60. doi: 10.1161/CIRCULATIONAHA.109.192704. Epub 2010 Feb 8.
Abstract
摘要
相似文献
1
Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation.
Circulation. 2010 Mar 2;121(8):1047-60. doi: 10.1161/CIRCULATIONAHA.109.192704. Epub 2010 Feb 8.
2
Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation.
J Am Coll Cardiol. 2010 Mar 2;55(9):934-47. doi: 10.1016/j.jacc.2010.01.001.
3
Prevention of torsade de pointes in the congenital long QT syndrome: use of a pause prevention pacing algorithm.
Heart. 1998 Apr;79(4):417-9. doi: 10.1136/hrt.79.4.417.
4
Spontaneous sequences of onset of torsade de pointes in patients with acquired prolonged repolarization: quantitative analysis of Holter recordings.
J Am Coll Cardiol. 1995 Jun;25(7):1564-75. doi: 10.1016/0735-1097(95)00100-i.
5
Nicorandil successfully abolished intraoperative torsade de pointes.
Anesthesiology. 1998 Jun;88(6):1669-71. doi: 10.1097/00000542-199806000-00033.
6
Drug therapy for torsade de pointes.
J Cardiovasc Electrophysiol. 1993 Apr;4(2):206-10. doi: 10.1111/j.1540-8167.1993.tb01224.x.
7
A practical approach to torsade de pointes.
Clin Cardiol. 1997 Mar;20(3):285-90. doi: 10.1002/clc.4960200318.
8
Torsades de Pointes: 50 Years Later, Can We See It Coming?
Circ Arrhythm Electrophysiol. 2016 Feb;9(2):e003850. doi: 10.1161/CIRCEP.116.003850.
9
Preventing torsades de pointes by careful cardiac monitoring in hospital settings.
AACN Adv Crit Care. 2007 Jul-Sep;18(3):285-93. doi: 10.4037/15597768-2007-3007.
10
Short-coupled variant of torsade de pointes. A new electrocardiographic entity in the spectrum of idiopathic ventricular tachyarrhythmias.
Circulation. 1994 Jan;89(1):206-15. doi: 10.1161/01.cir.89.1.206.
引用本文的文献
1
Prognostic Significance of aVR Lead and QTc Prolongation in Patients with Early Repolarization.
Medicina (Kaunas). 2025 Aug 14;61(8):1466. doi: 10.3390/medicina61081466.
2
Population prevalence and correlates of prolonged and shortened QTc intervals in a nationwide survey of adults in China: a report from Chinese arrhythmia epidemiology cross-sectional study.
Front Cardiovasc Med. 2025 Jul 31;12:1555512. doi: 10.3389/fcvm.2025.1555512. eCollection 2025.
3
Torsade de Pointes and QT Prolongation Among Antifungal Triazoles: A Real-World, Retrospective, Observational, Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (FAERS) Database.
Cardiovasc Toxicol. 2025 Aug 6. doi: 10.1007/s12012-025-10051-1.
4
Anti-Ro/SSA antibodies in adult arrhythmias: pathogenesis, clinical implications, and therapeutic strategies.
Front Immunol. 2025 May 5;16:1561061. doi: 10.3389/fimmu.2025.1561061. eCollection 2025.
5
Dihydrotestosterone Pretreatment Diminishes the Severity of Drug-Induced Torsades de Pointes.
J Cardiovasc Pharmacol. 2025 May 8. doi: 10.1097/FJC.0000000000001716.
6
Pharmacokinetics and Safety of Oral Pyrophosphate in Systemic Sclerosis Patients-A Pilot Study.
ACR Open Rheumatol. 2025 Apr;7(4):e70036. doi: 10.1002/acr2.70036.
7
Real-World Data on Osimertinib-Associated Cardiac Toxicity.
J Clin Med. 2025 Mar 5;14(5):1754. doi: 10.3390/jcm14051754.
8
QT Interval, Antipsychotics and Correlates Among Patients with Schizophrenia: Cross-Sectional Data from the Multicentric Real-World FACE-SZ.
Drug Saf. 2025 Mar 15. doi: 10.1007/s40264-025-01526-9.
9
Management of Cardiac Rhythm Disorders in Cardio-oncology.
Arrhythm Electrophysiol Rev. 2025 Feb 20;14:e05. doi: 10.15420/aer.2024.20. eCollection 2025.
10
The association between insulin resistance and QT interval: A systematic review and Meta-Analysis.
BMC Cardiovasc Disord. 2025 Feb 28;25(1):139. doi: 10.1186/s12872-025-04593-z.
本文引用的文献
1
QTc interval screening in methadone treatment.
Ann Intern Med. 2009 Mar 17;150(6):387-95. doi: 10.7326/0003-4819-150-6-200903170-00103. Epub 2009 Jan 19.
2
Atypical antipsychotic drugs and the risk of sudden cardiac death.
N Engl J Med. 2009 Jan 15;360(3):225-35. doi: 10.1056/NEJMoa0806994.
3
Drug induced QT prolongation.
Cardiol J. 2007;14(6):523-33.
4
Accurate electrocardiographic assessment of the QT interval: teach the tangent.
Heart Rhythm. 2008 Jul;5(7):1015-8. doi: 10.1016/j.hrthm.2008.03.037. Epub 2008 Apr 1.
5
Citalopram overdose: late presentation of torsades de pointes (TdP) with cardiac arrest.
J Med Toxicol. 2008 Jun;4(2):101-5. doi: 10.1007/BF03160963.
6
Overrepresentation of the proarrhythmic, sudden death predisposing sodium channel polymorphism S1103Y in a population-based cohort of African-American sudden infant death syndrome.
Heart Rhythm. 2008 May;5(5):712-5. doi: 10.1016/j.hrthm.2008.02.012. Epub 2008 Feb 16.
7
Drug-induced torsades de pointes: a review of the Swedish pharmacovigilance database.
Pharmacoepidemiol Drug Saf. 2008 Jun;17(6):587-92. doi: 10.1002/pds.1607.
8
Torsades de pointes related to transient marked QT prolongation following successful emergent percutaneous coronary intervention for acute coronary syndrome.
J Electrocardiol. 2008 Mar-Apr;41(2):117-22. doi: 10.1016/j.jelectrocard.2007.09.009.
9
Persistent atrial fibrillation is associated with reduced risk of torsades de pointes in patients with drug-induced long QT syndrome.
J Am Coll Cardiol. 2008 Feb 26;51(8):836-42. doi: 10.1016/j.jacc.2007.09.066.
10
Preventing torsades de pointes by careful cardiac monitoring in hospital settings.
AACN Adv Crit Care. 2007 Jul-Sep;18(3):285-93. doi: 10.4037/15597768-2007-3007.
Zotero 插件